HEB - Hemispherx Biopharma Inc.
Previous close
1.8
1.800 100.000%
Share volume: 0
Last Updated: Fri 30 Aug 2019 10:00:00 PM CEST
Biotechnology:
-0.86%
PREVIOUS CLOSE
CHG
CHG%
N/A
0.00
0.00%
Summary score
18%
Profitability
0%
Dept financing
20%
Liquidity
8%
Performance
38%
Sector
Health Technology
Industry
Biotechnology
Long-term ratios 30-Jun-2015 - 30-Jun-2019
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-27.64%
Return on assets
-17.42%
Return on sales
-8951.92%
Return on invested capital
-26.77%
Total debt ratio
41.99%
Debt ratio change over timeo
-4.12%
Current Ratio
2.09%
Quick Ratio
2.12%
Cash Position Ratio
0.83%
Short-term ratios 30-Jun-2018 - 30-Jun-2019
The data are presented for the financials results of the quarters of the last year.
Return on equity
-48.89%
Return on assets
-16.65%
Return on sales
-6740.24%
Return on invested capital
-32.11%
Total debt ratio
68.99%
Debt ratio change over timeo
-7.48%
Current Ratio
1.67%
Quick Ratio
0%
Cash Position Ratio
0.64%
Last quarter ratios 30-Jun-2019
The data are presented for the financials results of the last quarter.
Return on equity
-30.99%
Return on assets
-23.35%
Return on sales
-11117.24%
Return on invested capital
-24.43%
Total debt ratio
52.58%
Debt ratio change over time
-2.25%
Current Ratio
2.15%
Quick Ratio
0%
Cash Position Ratio
0.55%
Performance ratios (change over 4 years) 30-Jun-2015 - 30-Jun-2019
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
187.33%
Return on assets
11.79%
Return on sales
31974.74%
Return on invested capital
101.92%
Total debt ratio
-412.06%
Debt ratio change over time
-4.12%
Current Ratio
-15.28%
Quick Ratio
0%
Cash Position Ratio
-6.73%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | HEB | IMMU | MNTA | ONCE |
|---|---|---|---|---|
| Return on equity | -27.64% | -5.61% | -10.5% | -11.67% |
| Return on assets | -17.42% | -20.86% | -8.18% | -9.47% |
| Return on sales | -8951.92% | -5539.23% | 0% | -356.65% |
| Return on invested capital | -26.77% | 354.56% | -245.62% | -123.06% |
| Profitability | 0% | 50% | 50% | 0% |
| Total debt ratio | 41.99% | 135.51% | 24.76% | 24.16% |
| Debt ratio change over time | -4.12% | 0.12% | -1.08% | -1.38% |
| Dept financing | 8% | 50% | 5% | 4% |
| Current Ratio | 1.67% | 11.79% | 7.07% | 7.83% |
| Quick Ratio | 0% | 0% | 0% | 7.46% |
| Cash Position Ratio | 0.64% | 11.51% | 3.1% | 1.63% |
| Liquididy | 14% | 46% | 25% | 59% |
| Short-term ratios | HEB | IMMU | MNTA | ONCE |
|---|---|---|---|---|
| Return on equity | -48.89% | -42.29% | -17.27% | -12.45% |
| Return on assets | -16.65% | -16.67% | -11.14% | -7.48% |
| Return on sales | -6740.24% | 0% | 0% | -422.62% |
| Return on invested capital | -32.11% | 675.1% | -305.46% | -38.28% |
| Profitability | 0% | 25% | 25% | 50% |
| Total debt ratio | 68.99% | 57.87% | 25.5% | 39.42% |
| Debt ratio change over time | -7.48% | -0.87% | -1.62% | -1.81% |
| Dept financing | 25% | 46% | 9% | 14% |
| Current Ratio | 1.67% | 11.79% | 7.07% | 7.83% |
| Quick Ratio | 0% | 0% | 0% | 7.46% |
| Cash Position Ratio | 0.64% | 11.51% | 3.1% | 1.63% |
| Liquididy | 5% | 50% | 22% | 45% |